The bioanalytical services market is expected to witness abundance of growth opportunities in the upcoming years. The increasing number of infectious diseases is anticipated to revive the growth of the bioanalytical services market. Many pharmaceutical companies are now collaborating with research institutes to provide necessary bioanalyical services. Bioanalytical services involve pre-clinical tests, fluid or specimen testing, analysis of clinical samples, investigation of infection of viruses in the body, etc. In the global pandemic, these services have created significant growth opportunities for market contributors. Bioanalytical services played a major role in COVID-19 drug investigation and vaccination programs. Ongoing assays, vaccine testing solutions, drug inspection procedures, and technological advancement in pharmaceutical companies are creating revenue opportunities amid pandemic in the bioanalytical services market.
Dearth of highly skilled and productive manpower is one of the major challenges faced by many market contributors of the bioanaytical services market. Bioanalytical laboratories and research centers require skilled and experienced professionals to study and develop innovative solutions to fulfill the increasing demand of bioanalytical testing services from medical industry. In order to overcome this, governments are investing on providing training, webinars for students and graduate-level scientists to educate and keep themselves updated with the latest trends, and recent technological advancements. Moreover, to minimize the complexities in bioanalytics, acceptance and investment in new technologies, making use of better tools, and equipment for accurate sample analysis are required.
The bioanalytical services market is projected to reach US$ 12.34 Bn by 2031. Manufacturers are bolstering their R&D capabilities to experiment with new technologies and applications. Escalating complexity and number of standards are driving the bioanalytical services market. Pharmaceutical companies are establishing their foot in outsourcing R&D activities to various contact research organizations to stay ahead of the competition and generate more revenue opportunities. Increasing government expenditure on healthcare, research & development activities, and trending advances in bioinformatics also strengthen the scope and expansion of CROs. Oncology is also a highly demanding branch of medicine that deals in diagnosis and treatment of cancer. The introduction of Big Data and artificial intelligence in medical field also elevate the demand in the bioanalytical services market.
Research & development activities have gained momentum in the field of drug development life cycles, pharmaceuticals, biopharmaceuticals, vaccinating procedures, and biosimilars since the coronavirus pandemic outbreak. The bioanalytical services have played an important role in the mitigation of the COVID-19 pandemic. Prevention and control of future waves of the various other infectious diseases such as SARS-CoV-2, HIV, etc. is extremely necessary these days, and thus, bioanalytical testing services are advantageous in many ways. There is an increasing demand for small molecular and large molecular bioanalytical services such as electrophoresis, tissue bioanalysis, immunochemistry services, electrochemical and titrimetric assays, immunoassays, etc. The high demand for these services are translating into lucrative revenue opportunities for manufacturers in the bioanalyttical services market.
The bioanalytical services market is expected to advance at a CAGR of 8.2% during the forecast period. Pharmaceutical companies are increasing their output capacities in pre-clinical testing methods, drug safety, etc. with changing guidelines of international organizations. Thus, to understand the complex and changing standards in testing methods, clinical trials, and regulatory updates, governments are taking a step ahead to support manufacturers in the pharmaceutical companies, and investing in research and development activities. Bianalytical services are beneficial in early detection of coronavirus, and governments of various countries are supporting for the same. Increasing healthcare expenditure, outsourcing research activities by pharmaceutical companies in the bioanalytical services market help elevate the economy.
The increasing prevalence of infectious as well as chronic diseases such as diabetes all over the world demand for bioanalytical testing services. A large number of ongoing clinical trials, outsourcing services, research activities, and increasing investment by major pharmaceutical companies are some of the factors responsible for the growth of the bioanalytical services market in North America. The rapid increase in manufacturing of pharmaceuticals to fulfill consistently rising demand for healthcare services in the region is expected to propel the development of the bioanalytics services market in the region.
Manufacturers operating in the bioanalytical services market are shifting toward electronics medical devices to increase the performance of the services. Countries in the Asia Pacific market such as China, India, Japan, etc. are the fastest growing markets in providing and outsourcing bioanalytical services. Increasing investments on healthcare and highly efficient pharmaceutical outsourcing services are the two important factors that are boosting the market growth in Asia Pacific.
Analysts’ Viewpoint
Experienced scientists are developing innovative methods to detect drug metabolites, drug analysis, and validation requirements by considering various regulatory and non-regulatory guidelines and standardizations. Drug samples can be analyzed by ensuring the quality, stability, and accuracy. Technological advancements in healthcare and pharmaceutical industries have the potential to create more revenue opportunities post COVID-19 period. Although there are some challenges in the bioanalytical services market that we need to overcome in the upcoming years such as lack of skilled professionals, methods to deal with highly complex, unstable drug compounds, etc. Hence, companies in the bioanalytical services market should experiment with new techniques to improvise the testing processes. In addition, elemental bioanalysis, biosimilar analysis, and validation methods are also contributing toward market expansion.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 5.4 Bn |
|
Market Forecast Value in 2031 |
USD$ 12.4 Bn |
|
Growth Rate (CAGR) |
8.2% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview. |
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Bioanalytical Services Market – Segmentation
| Service |
|
| Type |
|
| End-user |
|
| Region |
|
Bioanalytical services market is projected to reach US$ 12.34 Bn by 2031
Bioanalytical services market is projected to expand at a CAGR of 8.2% from 2021 to 2031
Bioanalytical services market is driven by rise in prevalence of infectious diseases, HIV, and other diseases.
The small molecule bioanalysis segment dominated the global bioanalytical services market and the trend is likely to continue during the forecast period.
Key Players in bioanalytical services market include PPD, Inc., ICON plc, Laboratory Corporation of America, Charles River Laboratories International, Inc., Syneos Health, SGS SA
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioanalytical Services Market
4. Market Overview
4.1. Introduction
4.1.1. Services Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioanalytical Services Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Technological Advancements
6. Global Bioanalytical Services Market Analysis and Forecast, by Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Services, 2017–2031
6.3.1. Immunochemistry Service
6.3.2. Quantitative Immunoassays
6.3.3. Cell-Based Neutralization Assays
6.3.4. LCMS Method Development
6.3.5. Discovery Phase Bioanalysis
6.3.6. LCMS Sample Bioanalysis
6.3.7. GCP Bioanalysis Service
6.3.8. Biomarker Assays
6.3.9. Protein Analysis
6.3.10. Others
6.4. Market Attractiveness By Service
7. Global Bioanalytical Services Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017–2031
7.3.1. Small Molecule Bioanalysis
7.3.2. Large Molecule Bioanalysis
7.3.3. Others
7.4. Market Attractiveness Analysis, by Type
8. Global Bioanalytical Services Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Pharma & Biotechnology Companies
8.3.2. Contract Research Organizations
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Bioanalytical Services Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Bioanalytical Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Service, 2017–2031
10.2.1. Immunochemistry Service
10.2.2. Quantitative Immunoassays
10.2.3. Cell-Based Neutralization Assays
10.2.4. LCMS Method Development
10.2.5. Discovery Phase Bioanalysis
10.2.6. LCMS Sample Bioanalysis
10.2.7. GCP Bioanalysis Service
10.2.8. Biomarker Assays
10.2.9. Protein Analysis
10.2.10. Others
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. Small Molecule Bioanalysis
10.3.2. Large Molecule Bioanalysis
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Pharma & Biotechnology Companies
10.4.2. Contract Research Organizations
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Service
10.6.2. By Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Bioanalytical Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Service, 2017–2031
11.2.1. Immunochemistry Service
11.2.2. Quantitative Immunoassays
11.2.3. Cell-Based Neutralization Assays
11.2.4. LCMS Method Development
11.2.5. Discovery Phase Bioanalysis
11.2.6. LCMS Sample Bioanalysis
11.2.7. GCP Bioanalysis Service
11.2.8. Biomarker Assays
11.2.9. Protein Analysis
11.2.10. Others
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Small Molecule Bioanalysis
11.3.2. Large Molecule Bioanalysis
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Pharma & Biotechnology Companies
11.4.2. Contract Research Organizations
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Service
11.6.2. By Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Bioanalytical Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Service, 2017–2031
12.2.1. Immunochemistry Service
12.2.2. Quantitative Immunoassays
12.2.3. Cell-Based Neutralization Assays
12.2.4. LCMS Method Development
12.2.5. Discovery Phase Bioanalysis
12.2.6. LCMS Sample Bioanalysis
12.2.7. GCP Bioanalysis Service
12.2.8. Biomarker Assays
12.2.9. Protein Analysis
12.2.10. Others
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. Small Molecule Bioanalysis
12.3.2. Large Molecule Bioanalysis
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Pharma & Biotechnology Companies
12.4.2. Contract Research Organizations
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Service
12.6.2. By Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Bioanalytical Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Service, 2017–2031
13.2.1. Immunochemistry Service
13.2.2. Quantitative Immunoassays
13.2.3. Cell-Based Neutralization Assays
13.2.4. LCMS Method Development
13.2.5. Discovery Phase Bioanalysis
13.2.6. LCMS Sample Bioanalysis
13.2.7. GCP Bioanalysis Service
13.2.8. Biomarker Assays
13.2.9. Protein Analysis
13.2.10. Others
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. Small Molecule Bioanalysis
13.3.2. Large Molecule Bioanalysis
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Pharma & Biotechnology Companies
13.4.2. Contract Research Organizations
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Service
13.6.2. By Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Bioanalytical Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Service, 2017–2031
14.2.1. Immunochemistry Service
14.2.2. Quantitative Immunoassays
14.2.3. Cell-Based Neutralization Assays
14.2.4. LCMS Method Development
14.2.5. Discovery Phase Bioanalysis
14.2.6. LCMS Sample Bioanalysis
14.2.7. GCP Bioanalysis Service
14.2.8. Biomarker Assays
14.2.9. Protein Analysis
14.2.10. Others
14.3. Market Value Forecast, by Type, 2017–2031
14.3.1. Small Molecule Bioanalysis
14.3.2. Large Molecule Bioanalysis
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Pharma & Biotechnology Companies
14.4.2. Contract Research Organizations
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Service
14.6.2. By Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. PPD, Inc.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. ICON plc
15.4.2.1. Company Description
15.4.2.2. Business Overview
15.4.2.3. Financial Overview
15.4.2.4. SWOT Analysis
15.4.3. Laboratory Corporation of America
15.4.3.1. Company Description
15.4.3.2. Business Overview
15.4.3.3. Financial Overview
15.4.3.4. SWOT Analysis
15.4.4. Charles River Laboratories International, Inc.
15.4.4.1. Company Description
15.4.4.2. Business Overview
15.4.4.3. Financial Overview
15.4.4.4. SWOT Analysis
15.4.5. Syneos Health
15.4.5.1. Company Description
15.4.5.2. Business Overview
15.4.5.3. Financial Overview
15.4.5.4. SWOT Analysis
15.4.6. SGS SA
15.4.6.1. Company Description
15.4.6.2. Business Overview
15.4.6.3. SWOT Analysis
15.4.7. Toxikon, Inc.
15.4.7.1. Company Description
15.4.7.2. Business Overview
15.4.7.3. SWOT Analysis
15.4.8. Intertek Group
15.4.8.1. Company Description
15.4.8.2. Business Overview
15.4.8.3. Financial Overview
15.4.8.4. SWOT Analysis
15.4.9. Pace Analytical Services
15.4.9.1. Company Description
15.4.9.2. Business Overview
15.4.9.3. SWOT Analysis
15.4.10. Medpace
15.4.10.1. Company Description
15.4.10.2. Business Overview
15.4.10.3. Financial Overview
15.4.10.4. SWOT Analysis
15.4.11. PRA HEALTH SCIENCES
15.4.11.1. Company Description
15.4.11.2. Business Overview
15.4.11.3. Financial Overview
15.4.11.4. SWOT Analysis
15.4.12. WuXi AppTec
15.4.12.1. Company Description
15.4.12.2. Business Overview
15.4.12.3. Financial Overview
15.4.12.4. SWOT Analysis
15.4.13. IQVIA
15.4.13.1. Company Description
15.4.13.2. Business Overview
15.4.13.3. Financial Overview
15.4.13.4. SWOT Analysis
15.4.14. Eurofins Scientific
15.4.14.1. Company Description
15.4.14.2. Business Overview
15.4.14.3. Financial Overview
15.4.14.4. SWOT Analysis
List of Tables
Table 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 02: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 03: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 07: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 08: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 11: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 12: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 15: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 16: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 19: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 20: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 23: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 24: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Bioanalytical Services Market Value Share, by Type, 2020
Figure 03: Global Bioanalytical Services Market Value Share, by Region, 2020
Figure 04: Global Bioanalytical Services Market Value Share, by Service, 2020
Figure 05: Global Bioanalytical Services Market Value Share, by End-user, 2020
Figure 06: Global Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031
Figure 07: Global Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031
Figure 08: Global Bioanalytical Services Market Revenue (US$ Mn), by Immunochemistry Services, 2017–2031
Figure 09: Global Bioanalytical Services Market Revenue (US$ Mn), by Quantitative Immunoassays, 2017–2031
Figure 10: Global Bioanalytical Services Market Revenue (US$ Mn), by Cell-Based Neutralization Assays, 2017–2031
Figure 11: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Method Development, 2017–2031
Figure 12: Global Bioanalytical Services Market Revenue (US$ Mn), by Discovery Phase Bioanalysis, 2017–2031
Figure 13: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Sample Bioanalysis, 2017–2031
Figure 14: Global Bioanalytical Services Market Revenue (US$ Mn), by GCP Bioanalysis Service, 2017–2031
Figure 15: Global Bioanalytical Services Market Revenue (US$ Mn), by Biomarker Assays, 2017–2031
Figure 16: Global Bioanalytical Services Market Revenue (US$ Mn), by Protein Analysis, 2017–2031
Figure 17: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031
Figure 18: Global Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031
Figure 19: Global Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031
Figure 20: Global Bioanalytical Services Market Revenue (US$ Mn), by Small Molecule Bioanalysis, 2017–2031
Figure 21: Global Bioanalytical Services Market Revenue (US$ Mn), by Large Molecule Bioanalysis, 2017–2031
Figure 22: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031
Figure 23: Global Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031
Figure 24: Global Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031
Figure 25: Global Bioanalytical Services Market Value (US$ Mn), by Pharma & Biotechnology Companies, 2017–2031
Figure 26: Global Bioanalytical Services Market Value (US$ Mn), by Contract Research Organizations, 2017–2031
Figure 27: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031
Figure 28: Global Bioanalytical Services Market Value Share Analysis, by Region, 2020 and 2031
Figure 29: Global Bioanalytical Services Market Attractiveness Analysis, by Region, 2021–2031
Figure 30: North America Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 31: North America Bioanalytical Services Market Value Share, by Country, 2020–2031
Figure 32: North America Bioanalytical Services Market Attractiveness Analysis, by Country, 2021–2031
Figure 33: North America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031
Figure 34: North America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031
Figure 35: North America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031
Figure 36: North America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031
Figure 37: North America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031
Figure 38: North America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031
Figure 39: Europe Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 40: Europe Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 41: Europe Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 42: Europe Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031
Figure 43: Europe Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031
Figure 44: Europe Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031
Figure 45: Europe Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031
Figure 46: Europe Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031
Figure 47: Europe Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031
Figure 48: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 49: Asia Pacific Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 50: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 51: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031
Figure 52: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031
Figure 53: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031
Figure 54: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031
Figure 55: Asia Pacific Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031
Figure 56: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031
Figure 57: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 58: Latin America Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031
Figure 59: Latin America Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 60: Latin America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031
Figure 61: Latin America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031
Figure 62: Latin America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031
Figure 63: Latin America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031
Figure 64: Latin America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031
Figure 65: Latin America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031
Figure 66: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 67: Middle East & Africa Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031
Figure 68: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 69: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031
Figure 70: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031
Figure 71: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031
Figure 72: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031
Figure 73: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031
Figure 74: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bioanalytical Services Market Forecast Report, 2021-2031
